1. Home
  2. BMRN vs SWKS Comparison

BMRN vs SWKS Comparison

Compare BMRN & SWKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BMRN
  • SWKS
  • Stock Information
  • Founded
  • BMRN 1996
  • SWKS 1962
  • Country
  • BMRN United States
  • SWKS United States
  • Employees
  • BMRN N/A
  • SWKS N/A
  • Industry
  • BMRN Biotechnology: Pharmaceutical Preparations
  • SWKS Semiconductors
  • Sector
  • BMRN Health Care
  • SWKS Technology
  • Exchange
  • BMRN Nasdaq
  • SWKS Nasdaq
  • Market Cap
  • BMRN 11.1B
  • SWKS 11.4B
  • IPO Year
  • BMRN 1999
  • SWKS 1968
  • Fundamental
  • Price
  • BMRN $54.65
  • SWKS $74.54
  • Analyst Decision
  • BMRN Buy
  • SWKS Hold
  • Analyst Count
  • BMRN 20
  • SWKS 18
  • Target Price
  • BMRN $92.21
  • SWKS $72.69
  • AVG Volume (30 Days)
  • BMRN 2.2M
  • SWKS 2.7M
  • Earning Date
  • BMRN 10-28-2025
  • SWKS 11-11-2025
  • Dividend Yield
  • BMRN N/A
  • SWKS 3.77%
  • EPS Growth
  • BMRN 154.69
  • SWKS N/A
  • EPS
  • BMRN 3.40
  • SWKS 2.50
  • Revenue
  • BMRN $3,063,608,000.00
  • SWKS $4,011,700,000.00
  • Revenue This Year
  • BMRN $13.35
  • SWKS N/A
  • Revenue Next Year
  • BMRN $9.18
  • SWKS N/A
  • P/E Ratio
  • BMRN $16.09
  • SWKS $29.69
  • Revenue Growth
  • BMRN 18.36
  • SWKS N/A
  • 52 Week Low
  • BMRN $52.48
  • SWKS $47.93
  • 52 Week High
  • BMRN $73.51
  • SWKS $101.50
  • Technical
  • Relative Strength Index (RSI)
  • BMRN 47.87
  • SWKS 43.78
  • Support Level
  • BMRN $53.19
  • SWKS $75.63
  • Resistance Level
  • BMRN $54.50
  • SWKS $78.26
  • Average True Range (ATR)
  • BMRN 1.20
  • SWKS 2.41
  • MACD
  • BMRN 0.29
  • SWKS -0.50
  • Stochastic Oscillator
  • BMRN 62.43
  • SWKS 0.50

About BMRN BioMarin Pharmaceutical Inc.

BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments aimed at addressing complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria (PKU), hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development.

About SWKS Skyworks Solutions Inc.

Skyworks Solutions produces semiconductors for wireless handsets and other devices that are used to enable wireless connectivity. Its main products include power amplifiers, filters, switches, and integrated front-end modules that support wireless transmissions. Skyworks' customers are mostly large smartphone manufacturers, but the firm also has a growing presence in nonhandset applications such as wireless routers, medical devices, and automobiles.

Share on Social Networks: